| Dr Charles Joseph Schmitt, MD | |
|
760 College Parkway, Colchester, VT 05445-3007 | |
| (802) 847-1170 | |
| Not Available |
| Full Name | Dr Charles Joseph Schmitt |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 35 Years |
| Location | 760 College Parkway, Colchester, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013118157 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Analysis of data from an institutional patient registry on stereotactic body radiotherapy (SBRT) indicates excellent long-term, local control, 79 percent of tumors, for medically inoperable, early stage lung cancer patients treated with SBRT from 2003 to 2012, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.
Virginia Tech faculty engineers and students are unravelling fundamental chemical and health properties of the chemical that contaminated the drinking water for the residents of West Virginia.
Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction and conducting clinical trials on its four lead drugs announced today the advancement of NCE001, from its proprietary methylphenidate derivatives family of compounds, to preclinical development for the treatment of glioblastoma multiforme, renal cell carcinoma and inflammatory breast cancer following the granting of multiple composition of matter and use patents in the USA, Canada, Europe and China.
According to researchers at Moffitt Cancer Center, cancer is subject to the evolutionary processes laid out by Charles Darwin in his concept of natural selection. Natural selection was the process identified by Darwin by which nature selects certain physical attributes, or phenotypes, to pass on to offspring to better "fit" the organism to the environment.
› Verified 5 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Analysis of data from an institutional patient registry on stereotactic body radiotherapy (SBRT) indicates excellent long-term, local control, 79 percent of tumors, for medically inoperable, early stage lung cancer patients treated with SBRT from 2003 to 2012, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.
Virginia Tech faculty engineers and students are unravelling fundamental chemical and health properties of the chemical that contaminated the drinking water for the residents of West Virginia.
Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction and conducting clinical trials on its four lead drugs announced today the advancement of NCE001, from its proprietary methylphenidate derivatives family of compounds, to preclinical development for the treatment of glioblastoma multiforme, renal cell carcinoma and inflammatory breast cancer following the granting of multiple composition of matter and use patents in the USA, Canada, Europe and China.
According to researchers at Moffitt Cancer Center, cancer is subject to the evolutionary processes laid out by Charles Darwin in his concept of natural selection. Natural selection was the process identified by Darwin by which nature selects certain physical attributes, or phenotypes, to pass on to offspring to better "fit" the organism to the environment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Joseph Schmitt, MD 790 College Pkwy, Colchester, VT 05446-3007 Ph: (802) 847-1170 | Dr Charles Joseph Schmitt, MD 760 College Parkway, Colchester, VT 05445-3007 Ph: (802) 847-1170 |
News Archive
Analysis of data from an institutional patient registry on stereotactic body radiotherapy (SBRT) indicates excellent long-term, local control, 79 percent of tumors, for medically inoperable, early stage lung cancer patients treated with SBRT from 2003 to 2012, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.
Virginia Tech faculty engineers and students are unravelling fundamental chemical and health properties of the chemical that contaminated the drinking water for the residents of West Virginia.
Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction and conducting clinical trials on its four lead drugs announced today the advancement of NCE001, from its proprietary methylphenidate derivatives family of compounds, to preclinical development for the treatment of glioblastoma multiforme, renal cell carcinoma and inflammatory breast cancer following the granting of multiple composition of matter and use patents in the USA, Canada, Europe and China.
According to researchers at Moffitt Cancer Center, cancer is subject to the evolutionary processes laid out by Charles Darwin in his concept of natural selection. Natural selection was the process identified by Darwin by which nature selects certain physical attributes, or phenotypes, to pass on to offspring to better "fit" the organism to the environment.
› Verified 5 days ago
Ms. Charlotte Ann Reback, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 790 College Pkwy, Colchester, VT 05446 Phone: 802-847-1170 | |
Dr. Terry R Stein, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 790 College Pkwy, Colchester, VT 05446 Phone: 802-847-1170 | |
Dr. Alicia A Jacobs, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 883 Blakely Rd, Colchester, VT 05446 Phone: 802-847-2055 | |
Dr. Allan M Ramsay, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 883 Blakely Rd, Colchester, VT 05446 Phone: 802-847-2055 | |
Sean T Maloney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 883 Blakely Rd, Colchester, VT 05446 Phone: 802-847-2055 Fax: 802-847-1688 | |
Carol Joy Gardner, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 905 Roosevelt Hwy Ste 210, Colchester, VT 05446 Phone: 802-879-6544 Fax: 802-879-0022 |